tradingkey.logo

Envoy Medical Inc

COCH

1.435USD

-0.010-0.69%
Horarios del mercado ETCotizaciones retrasadas 15 min
30.88MCap. mercado
PérdidaP/E TTM

Envoy Medical Inc

1.435

-0.010-0.69%
Más Datos de Envoy Medical Inc Compañía
Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.
Información de la empresa
Símbolo de cotizaciónCOCH
Nombre de la empresaEnvoy Medical Inc
Fecha de salida a bolsaMar 02, 2021
Director ejecutivoMr. Brent T. Lucas
Número de empleados42
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 02
Dirección4875 White Bear Parkway
CiudadWHITE BEAR LAKE
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal55110
Teléfono16513618000
Sitio Webhttps://www.envoymedical.com/
Símbolo de cotizaciónCOCH
Fecha de salida a bolsaMar 02, 2021
Director ejecutivoMr. Brent T. Lucas
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Glen A. Taylor
Mr. Glen A. Taylor
Chairman Emeritus
Chairman Emeritus
10.29M
--
Mr. Brent T. Lucas
Mr. Brent T. Lucas
Chief Executive Officer, Director
Chief Executive Officer, Director
209.46K
+3.84%
Mr. Charles R. Brynelsen
Mr. Charles R. Brynelsen
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
50.00K
--
Mr. Robert Potashnick
Mr. Robert Potashnick
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Ms. Susan J. Kantor
Ms. Susan J. Kantor
Independent Director
Independent Director
--
--
Ms. Janis Smith-Gomez
Ms. Janis Smith-Gomez
Independent Director
Independent Director
--
--
Mr. Michael Crowe
Mr. Michael Crowe
Independent Director
Independent Director
--
--
Ms. Mona Patel
Ms. Mona Patel
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Glen A. Taylor
Mr. Glen A. Taylor
Chairman Emeritus
Chairman Emeritus
10.29M
--
Mr. Brent T. Lucas
Mr. Brent T. Lucas
Chief Executive Officer, Director
Chief Executive Officer, Director
209.46K
+3.84%
Mr. Charles R. Brynelsen
Mr. Charles R. Brynelsen
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
50.00K
--
Mr. Robert Potashnick
Mr. Robert Potashnick
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Ms. Susan J. Kantor
Ms. Susan J. Kantor
Independent Director
Independent Director
--
--
Ms. Janis Smith-Gomez
Ms. Janis Smith-Gomez
Independent Director
Independent Director
--
--
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: mar., 29 de jul
Actualizado: mar., 29 de jul
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
NorthRock Partners, LLC
47.81%
Taylor (Glen A)
47.81%
Atlas Merchant Capital LLC
2.58%
The Vanguard Group, Inc.
1.84%
Weiss Asset Management
1.80%
Accionistas
Accionistas
Proporción
NorthRock Partners, LLC
47.81%
Taylor (Glen A)
47.81%
Atlas Merchant Capital LLC
2.58%
The Vanguard Group, Inc.
1.84%
Weiss Asset Management
1.80%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
52.76%
Individual Investor
49.91%
Private Equity
2.60%
Hedge Fund
2.34%
Investment Advisor/Hedge Fund
2.05%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
70
23.44M
109.92%
+6.87M
2025Q1
77
13.16M
66.71%
-3.62M
2024Q4
150
12.62M
59.27%
-33.88M
2024Q3
159
13.83M
66.11%
-35.76M
2024Q2
163
13.88M
70.79%
-37.22M
2024Q1
162
13.71M
69.92%
-38.36M
2023Q4
154
4.83M
24.67%
-35.19M
2023Q3
153
6.18M
31.55%
-33.86M
2023Q2
150
4.03M
92.35%
-36.92M
2023Q1
148
4.23M
95.61%
-38.32M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Taylor (Glen A)
10.29M
48.25%
--
--
Apr 10, 2025
Atlas Merchant Capital LLC
555.53K
2.6%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
394.96K
1.85%
--
--
Mar 31, 2025
Weiss Asset Management
387.97K
1.82%
-8.69K
-2.19%
Mar 31, 2025
Focus Partners Wealth, LLC
212.66K
1%
+115.69K
+119.30%
Mar 31, 2025
Lucas (Brent T)
209.46K
0.98%
+7.74K
+3.84%
May 30, 2025
Arcus Capital Partners, LLC
187.57K
0.88%
+187.57K
--
Mar 31, 2025
DSG Capital Advisors, LLC
163.64K
0.77%
--
--
Mar 31, 2025
Meteora Capital LLC
108.51K
0.51%
--
--
Apr 10, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proporción0%
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI